Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Self-Start Triage Model for Post-Botox® Lower Urinary Tract Symptoms
NCT07648290Phase 1Recruiting
- Sponsor
- Cleveland Clinic
- Start
- Jul 2026
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nitrofurantoin in urinary tract infection (UTI) (2 arms), sponsored by Cleveland Clinic. Primary endpoint: Healthcare utilization at 30 days. Started Jul 2026; status: recruiting.
02
Drugs
nitrofurantoin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT07648290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07648290.